Royce & Associates’s Delcath Systems DCTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-195,000
Closed -$1.81M 774
2026
Q1
$1.81M Buy
195,000
+40,000
+26% +$387K 0.02% 592
2025
Q4
$1.57M Buy
+155,000
New +$1.54M 0.02% 624

Other funds holding DCTH

Royce & Associates's DCTH Position: Q2 2026 in Review

Royce & Associates sold out of Delcath Systems (DCTH) in Q2 2026, closing a stake of 195,000 shares — an estimated $1.81M sold.

Royce & Associates first reported a position in DCTH in Q4 2025 and held it in 2 quarters. The position peaked at $1.81M in Q1 2026. 120 funds tracked by Wall St. Rank hold DCTH as of Q2 2026.

  • Royce & Associates reported no remaining Delcath Systems position as of Q2 2026 after selling out during the quarter.
  • Royce & Associates sold 195,000 Delcath Systems shares in Q2 2026, an estimated $1.81M.
  • Royce & Associates first reported a position in Delcath Systems in Q4 2025 and held it in 2 quarters.
  • Royce & Associates's Delcath Systems position peaked at $1.81M in Q1 2026.
  • 120 funds tracked by Wall St. Rank held Delcath Systems as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.